GENE ONLINE|News &
Opinion
Blog

Moderna
Editors' Picks weekly highlightsAustralia
GeneOnline’s Weekly News Highlights: Oct 30-Nov 3
2023-11-07
Asia-Pacific Australia
Moderna Launches mRNA Platform Incubator Network to Boost Australian mRNA Research
2023-11-06
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
Trials & Approvals ModernaCancer Vaccine
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Trials & Approvals ModernamRNA Vaccine
Moderna’s mRNA Flu Vaccine Development Slow Going as Data Rolls In
2023-04-11
Licensing Lipid Nanoparticle
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Special mRNA
A New Phase in Drug Development: Programming the Genome
2023-03-02
Partnerships Gene Editing
Moderna, Life Edit To Develop In Vivo Gene Editing Therapies
2023-02-23
Trials & Approvals RSV vaccines
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Trials & Approvals Moderna
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
Partnerships Moderna
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Partnerships Keytruda
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
COVID-19 Omicron
The COVID-19 Pandemic: Is Omicron the Last Variant?
2022-09-16
COVID-19 FDA
FDA Approves Both Moderna’s and Pfizer/BioNTech’s Omicron Bivalent Vaccines in One Day
2022-08-31
COVID-19 Moderna
Moderna Wins the First Regulatory Approval for an Omicron Bivalent Vaccine
2022-08-30
1 2 3 … 5
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top